| Chad Ryan Desmarteau, | |
|
2616 N High St, Denver, CO 80205-4542 | |
| (925) 964-3760 | |
| Not Available |
| Full Name | Chad Ryan Desmarteau |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 2616 N High St, Denver, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437755139 | NPI | - | NPPES |
| OT.0006606 | Other | CO | COLORADO DORA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT.0006606 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Chad Ryan Desmarteau, 2616 N High St, Denver, CO 80205-4542 Ph: () - | Chad Ryan Desmarteau, 2616 N High St, Denver, CO 80205-4542 Ph: (925) 964-3760 |
News Archive
Calibr, the drug development division of Scripps Research, announced today that the U.S. Food and Drug Administration has cleared its investigational new drug application for CCW702, a novel immunotherapeutic for the treatment of patients with metastatic castration-resistant prostate cancer.
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
Matthew D. McHugh, PhD, CRNP, MPH, JD, an assistant professor at the University of Pennsylvania School of Nursing, has won a competitive grant from the Robert Wood Johnson Foundation (RWJF) to study the relationships among where people live, where they receive hospital care, and the outcomes of that care.
Kyndra Nevin recalls with dread having to ask a Montana judge to sign an order documenting that she'd had gender-confirmation surgery so she could change the gender on her birth certificate to female.
Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.
› Verified 8 days ago
Kristin Turner, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3105 W Arkansas Ave, Denver, CO 80219 Phone: 303-936-3497 | |
American Council For Th Eblind And Visually Impaired Of Colorado Acbco Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 910 16th St Ste 1240, Denver, CO 80202 Phone: 303-831-0117 Fax: 303-454-3378 | |
Ana Nicole Miller, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2979 Uinta St, Denver, CO 80238 Phone: 720-787-7800 | |
Melanie Marie Shovlin, MS, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1460 S Saint Paul St, Denver, CO 80210 Phone: 303-550-5868 | |
Kristen Dorighi, MS, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1667 S Lafayette St, Denver, CO 80210 Phone: 303-715-4482 | |
Sarah Whitaker, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6060 E Iliff Ave, Denver, CO 80222 Phone: 303-759-4221 | |
Julie Brahen, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2201 N Downing St, Denver, CO 80205 Phone: 303-861-4825 |